Your browser is no longer supported. Please, upgrade your browser.
Settings
PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E23.67 EPS (ttm)1.67 Insider Own0.04% Shs Outstand5.58B Perf Week-2.95%
Market Cap223.91B Forward P/E11.50 EPS next Y3.43 Insider Trans-0.12% Shs Float5.57B Perf Month-1.42%
Income9.40B PEG1.88 EPS next Q0.98 Inst Own66.70% Short Float1.06% Perf Quarter10.37%
Sales46.41B P/S4.83 EPS this Y-33.10% Inst Trans-0.92% Short Ratio2.12 Perf Half Y1.99%
Book/sh12.29 P/B3.21 EPS next Y-8.21% ROA6.60% Target Price42.62 Perf Year24.13%
Cash/sh2.41 P/C16.38 EPS next 5Y12.57% ROE17.00% 52W Range29.96 - 43.08 Perf YTD7.25%
Dividend1.56 P/FCF45.14 EPS past 5Y2.20% ROI7.60% 52W High-8.36% Beta0.72
Dividend %3.95% Quick Ratio1.20 Sales past 5Y-3.00% Gross Margin91.00% 52W Low31.79% ATR0.60
Employees78500 Current Ratio1.50 Sales Q/Q44.60% Oper. Margin22.00% RSI (14)51.86 Volatility1.49% 1.44%
OptionableYes Debt/Eq0.58 EPS Q/Q95.10% Profit Margin23.90% Rel Volume0.70 Prev Close39.30
ShortableYes LT Debt/Eq0.52 EarningsMay 04 BMO Payout76.80% Avg Volume27.78M Price39.48
Recom2.60 SMA200.23% SMA501.26% SMA2007.72% Volume19,520,881 Change0.46%
May-06-21Downgrade Mizuho Buy → Neutral $42
Apr-07-21Resumed RBC Capital Mkts Sector Perform $42
Feb-04-21Upgrade DZ Bank Hold → Buy $41
Dec-16-20Downgrade RBC Capital Mkts Outperform → Sector Perform $43 → $42
Nov-19-20Resumed Goldman Neutral $40
Nov-10-20Resumed Bernstein Mkt Perform $42
Oct-12-20Downgrade Atlantic Equities Overweight → Neutral $44 → $39
Sep-29-20Initiated Berenberg Hold $38
Jun-16-20Initiated SVB Leerink Mkt Perform $40
Feb-27-20Upgrade Standpoint Research Hold → Buy
Feb-27-20Initiated Barclays Equal Weight $36
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Outperform $46
Oct-17-19Resumed BofA/Merrill Neutral $37
Jul-30-19Downgrade Morgan Stanley Overweight → Equal-Weight $48 → $40
Jul-30-19Downgrade BofA/Merrill Buy → Neutral
Jun-04-19Resumed Morgan Stanley Overweight $48
Feb-20-19Resumed Citigroup Neutral $41
Jan-31-19Upgrade Credit Suisse Neutral → Outperform
Jan-31-19Upgrade Argus Hold → Buy
Jun-17-21 04:47PM  
04:30PM  
03:55PM  
03:07PM  
02:20PM  
11:00AM  
10:19AM  
09:55AM  
07:12AM  
06:32AM  
06:00AM  
06:00AM  
03:05AM  
Jun-16-21 08:00PM  
08:00PM  
07:31PM  
06:11PM  
05:19PM  
04:38PM  
01:48PM  
11:22AM  
10:33AM  
10:00AM  
09:57AM  
09:38AM  
05:52AM  
05:28AM  
Jun-15-21 06:20PM  
03:20PM  
11:34AM  
10:59AM  
08:21AM  
06:47AM  
05:54AM  
04:38AM  
Jun-14-21 10:52PM  
10:40PM  
05:45PM  
04:48PM  
04:39PM  
02:47PM  
01:47PM  
01:27PM  
01:00PM  
12:56PM  
11:45AM  
10:11AM  
08:52AM  
07:00AM  
Jun-13-21 09:29AM  
06:05AM  
05:55AM  
Jun-12-21 11:30AM  
11:00AM  
10:23AM  
Jun-11-21 05:35PM  
03:26PM  
03:20PM  
02:57PM  
12:42PM  
09:32AM  
08:44AM  
08:41AM  
06:53AM  
06:33AM  
06:00AM  
03:23AM  
03:00AM  
Jun-10-21 08:00PM  
06:46PM  
05:47PM  
04:49PM  
04:32PM  
04:29PM  
04:11PM  
02:26PM  
02:22PM  
02:00PM  
11:46AM  
10:35AM  
10:05AM  
10:03AM  
08:40AM  
08:20AM  
08:14AM  
07:56AM  
06:30AM  
06:24AM  
04:53AM  
02:26AM  
02:00AM  
02:00AM  
02:00AM  
Jun-09-21 06:19PM  
05:20PM  
02:50PM  
02:40PM  
02:30PM  
02:14PM  
02:07PM  
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerMay 05Sale40.822,500102,05013,748May 07 04:10 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 27Option Exercise22.3529,838666,879153,338Mar 02 05:59 PM
JOHNSON RADY AExecutive Vice PresidentFeb 27Option Exercise22.3525,165562,43895,309Mar 02 05:59 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Option Exercise22.3571,8991,606,943193,474Mar 02 05:59 PM
YOUNG JOHN DGroup PresidentFeb 27Option Exercise22.35129,4192,892,515575,282Mar 02 05:59 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 27Option Exercise22.3553,9251,205,224150,172Mar 02 06:00 PM
BOURLA ALBERTChairman & CEOFeb 27Option Exercise22.3553,9251,205,224165,034Mar 02 05:34 PM
Carapezzi William R JRExecutive Vice PresidentFeb 27Option Exercise22.3521,570482,09072,522Mar 02 05:35 PM
DAMICO JENNIFER B.SVP & ControllerFeb 27Option Exercise22.359,886220,95223,745Mar 02 05:35 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 27Option Exercise22.35152,7853,414,745607,441Mar 02 05:35 PM
Hwang AngelaGroup PresidentFeb 27Option Exercise22.359,886220,95234,211Mar 02 05:35 PM
SAHNI PAYALExecutive Vice PresidentFeb 25Option Exercise22.899,982228,48822,949Mar 01 04:10 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise22.89163,3343,738,715579,791Mar 01 04:10 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8981,6671,869,358189,763Mar 01 04:10 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8937,658861,992100,937Mar 01 04:05 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise22.8999,8162,284,788178,092Mar 01 04:05 PM
Hwang AngelaGroup PresidentFeb 25Option Exercise22.8922,686519,28342,927Mar 01 04:01 PM
BOURLA ALBERTChairman & CEOFeb 25Option Exercise22.86163,3343,733,815245,037Mar 01 03:58 PM
Carapezzi William R JRExecutive Vice PresidentFeb 25Option Exercise22.8927,222623,11271,553Mar 01 03:58 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 25Option Exercise22.89163,3343,738,715588,584Mar 01 03:58 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8912,477285,59919,781Mar 01 03:55 PM
BOURLA ALBERTChairman & CEONov 09Sale41.94132,5085,557,38678,273Nov 10 05:55 PM
SUSMAN SALLYExecutive Vice PresidentNov 09Sale41.9443,6621,831,184108,096Nov 10 05:55 PM
PFIZER INC10% OwnerOct 27Buy10.001,200,00012,000,00027,349,211Oct 29 05:44 PM
BLAYLOCK RONALD EDirectorAug 06Buy38.5413,000501,08513,000Aug 10 08:07 AM